Lifestyle Intervention in Men with Advanced Prostate Cancer Receiving Androgen Suppression Therapy: A Feasibility Study

被引:128
作者
Bourke, Liam [2 ,3 ]
Doll, Helen [4 ]
Crank, Helen [2 ,3 ]
Daley, Amanda [5 ]
Rosario, Derek [6 ]
Saxton, John M. [1 ]
机构
[1] Univ E Anglia, Sch Allied Hlth Profess, Norwich NR4 7TJ, Norfolk, England
[2] Sheffield Hallam Univ, Fac Hlth & Wellbeing, Sheffield S1 1WB, S Yorkshire, England
[3] Sheffield Teaching Hosp NHS Fdn Trust, NIHR Cardiovasc Biomed Res Unit, Sheffield, S Yorkshire, England
[4] Univ E Anglia, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England
[5] Univ Birmingham, Dept Primary Care Clin Sci, Coll Med & Dent Sci, Birmingham, W Midlands, England
[6] Univ Sheffield, Royal Hallamshire Hosp, Acad Urol Unit, Dept Oncol, Sheffield S10 2JF, S Yorkshire, England
关键词
FACTOR-BINDING-PROTEINS; QUALITY-OF-LIFE; GROWTH-FACTOR-I; DEPRIVATION THERAPY; FUNCTIONAL ASSESSMENT; METABOLIC SYNDROME; DIETARY-FAT; PHYSICAL-ACTIVITY; AEROBIC EXERCISE; BONE METASTASES;
D O I
10.1158/1055-9965.EPI-10-1143
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Healthy lifestyle behaviors could have a role in ameliorating some of the adverse effects of androgen suppression therapy (AST) in men with prostate cancer. The primary aim of this study was to assess the feasibility of a tapered supervised exercise program in combination with dietary advice in men with advanced prostate cancer receiving AST. Methods: Advanced prostate cancer patients receiving AST for a minimum of 6 months were randomized to a 12-week lifestyle program comprising aerobic and resistance exercise, plus dietary advice (n = 25), or standard care (n = 25). Exercise behavior, dietary macronutrient intake, quality of life, fatigue, functional fitness, and biomarkers associated with disease progression were assessed at baseline, after the intervention, and at 6 months. Results: The lifestyle group showed improvements in exercise behavior (P < 0.001), dietary fat intake (P 0.001), total energy intake (P = 0.005), fatigue (P = 0.002), aerobic exercise tolerance (P < 0.001), and muscle strength (P = 0.033) compared with standard care controls. Although a high rate of attrition (44%) was observed at 6 months, the improvements in key health outcomes were sustained. No effects on clinical prostate cancer disease markers were observed. Conclusions: This preliminary evidence suggests that pragmatic lifestyle interventions have potential to evoke improvements in exercise and dietary behavior, in addition to other important health outcomes in men with advanced prostate cancer receiving AST. Impact: This study shows for the first time that pragmatic lifestyle interventions are feasible and could have a positive impact on health behaviors and other key outcomes in men with advanced prostate cancer receiving AST. Cancer Epidemiol Biomarkers Prev; 20(4); 647-57. (C) 2011 AACR.
引用
收藏
页码:647 / 657
页数:11
相关论文
共 41 条
  • [1] Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy
    Amling, CL
    Riffenburgh, RH
    Sun, L
    Moul, JW
    Lance, RS
    Kusuda, L
    Sexton, WJ
    Soderdahl, DW
    Donahue, TF
    Foley, JP
    Chung, AK
    McLeod, DG
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (03) : 439 - 445
  • [2] What is a pilot or feasibility study? A review of current practice and editorial policy
    Arain, Mubashir
    Campbell, Michael J.
    Cooper, Cindy L.
    Lancaster, Gillian A.
    [J]. BMC MEDICAL RESEARCH METHODOLOGY, 2010, 10
  • [3] Long-term effects of androgen deprivation therapy in prostate cancer patients
    Basaria, S
    Leib, J
    Tang, AM
    DeWeese, T
    Carducci, M
    Eisenberger, M
    Dobs, AS
    [J]. CLINICAL ENDOCRINOLOGY, 2002, 56 (06) : 779 - 786
  • [4] Changes in bone mineral density, lean body mass and fat content as measured by dual energy X-ray absorptiometry in patients with prostate cancer without apparent bone metastases given androgen deprivation therapy
    Berruti, A
    Dogliotti, L
    Terrone, C
    Cerutti, S
    Isaia, G
    Tarabuzzi, R
    Reimondo, G
    Mari, M
    Ardissone, P
    De Luca, S
    Fasolis, G
    Fontana, D
    Rossetti, SR
    Angeli, A
    [J]. JOURNAL OF UROLOGY, 2002, 167 (06) : 2361 - 2367
  • [5] SIT-TO-STAND TEST FOR MEASURING PERFORMANCE OF LOWER-EXTREMITY MUSCLES
    BOHANNON, RW
    [J]. PERCEPTUAL AND MOTOR SKILLS, 1995, 80 (01) : 163 - 166
  • [6] PSYCHOPHYSICAL BASES OF PERCEIVED EXERTION
    BORG, GAV
    [J]. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 1982, 14 (05) : 377 - 381
  • [7] Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy
    Braga-Basaria, Milena
    Dobs, Adrian S.
    Muller, Denis C.
    Carducci, Michael A.
    John, Majnu
    Egan, Josephine
    Basaria, Shehzad
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (24) : 3979 - 3983
  • [8] Campbell MK, 2007, HEALTH TECHNOL ASSES, V11
  • [9] Combining anchor and distribution-based methods to derive minimal clinically important differences on the functional assessment of cancer therapy (FACT) anemia and fatigue scales
    Cella, D
    Eton, DT
    Lai, JS
    Peterman, AH
    Merkel, DE
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2002, 24 (06) : 547 - 561
  • [10] Estimating Clinically Meaningful Changes for the Functional Assessment of Cancer Therapy-Prostate: Results from a Clinical Trial of Patients with Metastatic Hormone-Refractory Prostate Cancer
    Cella, David
    Nichol, Michael B.
    Eton, David
    Nelson, Joel B.
    Mulani, Parvez
    [J]. VALUE IN HEALTH, 2009, 12 (01) : 124 - 129